Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

DOI Full Paper Access

44

Citations

16

References

2021

Year

David Cibula, Lukáš Rob, Peter Mallmann, Paweł Knapp, Jaroslav Klát, Josef Chovanec, Luboš Minář, Bohuslav Melichar, Alexander Hein, Dariusz Kieszko,

Gynecologic Oncology

References

	Year	Citations

Page 1